Bausch & Lomb Corp Income Statement
BLCO / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Bausch & Lomb Corp reported $5.1B in revenue and $360M in net loss for FY2025. Revenue has grown at a 8.4% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.1B | $4.8B | $4.1B | $3.8B | $3.8B | $3.4B |
| SG&A Expense | $2.2B | $2.1B | $1.7B | $1.5B | $1.4B | $1.3B |
| R&D Expense | $371.0M | $343.0M | $324.0M | $307.0M | $271.0M | $253.0M |
| Operating Income | $113.0M | $162.0M | $130.0M | $207.0M | $329.0M | $260.0M |
| Interest Expense | $421.0M | $399.0M | $283.0M | $146.0M | $0 | $0 |
| Income Tax | $35.0M | $71.0M | $82.0M | $58.0M | $125.0M | $307.0M |
| Net Income | -$360.0M | -$317.0M | -$260.0M | $6.0M | $182.0M | -$18.0M |
| EPS (Basic) | -$0.74 | $0.02 | $0.52 | -$0.05 | $0.52 | -$0.05 |
| EPS (Diluted) | -$0.74 | $0.02 | $0.52 | -$0.05 | $0.52 | -$0.05 |
| Shares Outstanding | 352.4M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M |
| Operating Margin | 2.2% | 3.4% | 3.1% | 5.5% | 8.7% | 7.6% |
| Profit Margin | -7.1% | -6.6% | -6.3% | 0.2% | 4.8% | -0.5% |